There are two main approaches used to design replication-competent adenoviruses in a tumor/tissue-specific manner: 1) the restrictive expression of the replication-essential viral proteins E1A, E1B, and E4 in target cells using tissue- or tumor-specific promoters and 2) the deletion of replication-critical genes. This evidence concerns the gene DHTKD1 and neoplasm.